Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GRI BIO, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 83.3K | Sep 22, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GRI | GRI BIO, Inc. | Sep 22, 2023 | 1 | $127K | 4 | Sep 26, 2023 | Chief Financial Officer |
GRI | Vallon Pharmaceuticals, Inc. | Feb 15, 2022 | 1 | $282K | 4 | Mar 1, 2022 | Chief Financial Officer |
GRI | Vallon Pharmaceuticals, Inc. | Jun 2, 2021 | 3 | $25.2K | 4 | Jun 4, 2021 | Chief Financial Officer |
GRI | Vallon Pharmaceuticals, Inc. | May 14, 2021 | 1 | $0 | 4 | May 18, 2021 | Chief Financial Officer |
GRI | Vallon Pharmaceuticals, Inc. | May 11, 2021 | 0 | $0 | 3 | May 18, 2021 | Chief Financial Officer |